Author:
McClanahan Fabienne,Hielscher Thomas,Rieger Michael,Hensel Manfred,Neben Kai,Hillengass Jens,Herfarth Klaus,Ho Anthony D.,Witzens-Harig Mathias
Subject
Hematology,General Medicine
Reference29 articles.
1. The Non-Hodgkin’s Lymphoma Classification Project;A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma;Blood,1997
2. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma;Marcus;Blood,2005
3. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group;Hiddemann;Blood,2005
4. Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study;Herold;J Clin Oncol,2007
5. Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study;Salles;Blood,2008
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献